Sign in Subscribe
Class action lawsuits

Centene Corporation Sued for Securities Fraud

Strategic Insights

— 1 min read

Investors in Centene Corporation, a healthcare company that focuses on government-sponsored healthcare programs and private insurance, are being encouraged to take action after a lawsuit was filed against the company and its senior executives for potential violations of federal securities laws. The law firm Bleichmar Fonti & Auld LLP has announced the class action lawsuit, which asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The lawsuit claims that the company misled investors with overly optimistic financial guidance, despite the majority of the market it serves experiencing lower-than-expected enrollment growth and increased morbidity rates.

Key Takeaways:

  • The lawsuit alleges that Centene's senior executives made false and misleading statements about the company's earnings and enrollment growth, which caused investors to lose millions of dollars.
  • The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Centene securities.
  • Centene's financial guidance was based on flawed assumptions about the healthcare market, which led to a 40% decline in the company's stock price.
  • The law firm Bleichmar Fonti & Auld LLP is representing investors in the case and seeks to recover losses for those who invested in Centene.
  • The case is pending in the U.S. District Court for the Southern District of New York and is captioned: Lunstrum v. Centene Corporation, et al., No. 25-cv-05659.
  • Investors have until September 8, 2025, to ask the Court to be appointed to lead the case.

Statistics:

  • The price of Centene stock fell $22.87 per share, or more than 40%, from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025.
  • Over 29 states were experiencing lower-than-expected enrollment growth and increased morbidity rates, according to an independent actuarial report from Wakely Consulting Group.
  • Centene's stock price decline resulted in millions of dollars in losses for investors.

Sources:

  • Press release from Bleichmar Fonti & Auld LLP announcing the class action lawsuit.
  • Law firm website: https://www.bfalaw.com
  • Securities and Exchange Commission (SEC) data and filings.
  • Newsfile Corp. publication date: August 4, 2025.

Read more